Effect on quality of life of switching to combined oral contraception based on natural estrogen: an observational, multicentre, prospective phase IV study (ZOCAL Study)

• Published in: The European journal of contraception & reproductive health care Vol. 21; no. 4; pp. 276 - 284
• Main Authors: Lete, Iñaki, de la Viuda, Esther, Pérez-Campos, Ezequiel, Martínez, María Ángeles Gómez, Sanchez-de la Rosa, Rainel, Novalbos, Jesús, Sánchez-Borrego, Rafael
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 01.08.2016; Taylor & Francis Ltd
• Subjects: Adolescent; Adult; Birth control; Combined oral contraception; Condoms - utilization; Contraceptives, Oral, Combined - adverse effects; Contraceptives, Oral, Combined - therapeutic use; E2V/DNG; Estrogens; Ethinyl Estradiol - adverse effects; Ethinyl Estradiol - therapeutic use; Female; Humans; Megestrol - adverse effects; Megestrol - analogs & derivatives; Megestrol - therapeutic use; Metrorrhagia - chemically induced; Middle Aged; Nandrolone - adverse effects; Nandrolone - analogs & derivatives; Nandrolone - therapeutic use; natural estrogen; NOMAC/E2; Patient Satisfaction; Premenstrual Syndrome - chemically induced; Prospective Studies; Quality of Life; Reproductive health; Womens health; Young Adult; Combined oral contraception; natural estrogen; quality of life; E2V/DNG; NOMAC/E2

Objectives: This observational, multicentre, prospective phase IV study examined change in health-related quality of life (QOL) from baseline to 6 months in women initiating combined oral contraception (COC) based on natural estrogen. Methods: Eligible women attending a baseline and 6-month gynaecol...